Measurement of drug concentration in brain and blood

DO Daisuke Ogasawara
TA Taka Aki-Ichu
VV Vincent Vartabedian
JB Jacqueline Benthuysen
HJ Hui Jing
AR Alex Reed
OU Olesya Ulanovskaya
JH Jonathan J. Hulce
AR Amanda Roberts
SB Steven Brown
HR Hugh Rosen
JT John R. Teijaro
BC Benjamin F. Cravatt
request Request a Protocol
ask Ask a question
Favorite

Measurement of tissue drug concentration was performed at Pharmaron (Bejing, China). DO264 and (S)-DO271 were administered as described above and incubated for 4 h. The brain tissues were homogenized with 4x volume of water (mL) by brain weight (g). Blood was collected via cardiac puncture and immediately quenched with acetonitrile at 1:4 blood:acetonitrile ratio. The brain homogenate and blood samples from drug-treated mice were diluted by 1000 to 2000-fold with 50% ACN in H2O. 5 μL of the diluted sample solutions were added to 50 μL of the blank C57BL/6J mice brain homogenate and blood respectively to make dose samples. For making calibration standards, the stock solutions of DO264 and (S)-DO271 (1 mg/mL in DMSO) were diluted with 50% ACN in H2O to generate serial concentrations of working solution. 5 μL of the working solutions (5, 10, 20, 50, 100, 500, 1000, 5000, 10000 ng/mL) were added to 50 μL of the blank C57BL/6J mice blood to achieve calibration standards of 0.5-1000 ng/mL (0.5, 1, 2, 5, 10, 50, 100, 500, 1000 ng/mL). 55 μL of calibration standards and 55 μL dose samples were added to 200 μL of ACN for precipitating protein respectively. Then the samples were vortexed for 30 s. After centrifugation at 4 °C, 4000 rpm for 15 min, the supernatant was diluted 5 times with water. 5 μL of the diluted supernatant was injected into the LC/MS/MS system for quantitative analysis (LCMS-8060, SHIMADZU).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A